Innophore

Executive Summary

Innophore is an Austrian AI-driven company specializing in enzyme and drug discovery. Founded in 2015 and based in Graz, the company offers a customizable platform that leverages machine learning to accelerate protein and drug discovery pipelines. By formulating each client's unique problem into a tailored computational solution, Innophore aims to augment R&D efficiency for pharmaceutical and biotechnology partners. Its focus on AI-powered protein engineering positions it within the growing computational drug discovery market, though the company remains private with limited public financial or operational details. The platform’s potential to reduce time and cost in early-stage discovery could drive adoption, but its impact depends on securing partnerships and validating its technology in real-world applications.

Upcoming Catalysts (preview)

• 2026Series A Funding Round50% success